HealthTree Podcast for Multiple Myeloma
210 episodes - English - Latest episode: 6 months ago - ★★★★★ - 13 ratingsHealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
mPatient Myeloma Radio: Dr. Jay Bradner, MD, Dana Farber Cancer Institute
August 29, 2014 21:00 - 1 hour - 17.9 MBJoin us as we talk with Dr. Jay Bradner, MD of the Bradner Lab, Dana Farber Cancer Institute and Harvard Medical School. Dr. Bradner focuses his research on the use of chemical biology to target gene regulatory pathways. Specifically, Dr. Bradner is working to develop a MYC inhibitor for myeloma. MYC is the most common translocation to be found in multiple myeloma and increases in prevalance as the disease progresses, so finding a target for this translocations is critical.
HealthTree Podcast for Myeloma: Dr. Antonio Palumbo, MD U of Torino, Italy
August 25, 2014 14:00 - 1 hour - 66.7 MBDo all multiple myeloma patients need continuous maintenance therapy? Join us as we talk with Dr. Antonio Palumbo, MD on HealthTree Podcast for Multiple Myeloma about the recent data to suggest that this may be the case.
mPatient Myeloma Radio: Dr. Antonio Palumbo, MD University of Torino, Italy
August 25, 2014 14:00 - 1 hour - 66.7 MBDo all multiple myeloma patients need continuous maintenance therapy? Join us as we talk with Dr. Antonio Palumbo, MD on mPatient Myeloma Radio about the recent data to suggest that this may be the case.
The New Hevylite® Myeloma Test with Dr. Stephen Harding, The Binding Site
July 18, 2014 15:00 - 1 hour - 15.1 MBJoin us as we learn more about the new Hevylite® test for myeloma patients - when it should be used and why it is important with Dr. Stephen Harding of The Binding Site.
HealthTree Podcast for Myeloma: Dr. Saad Usmani, MD, Levine Cancer Institute
June 27, 2014 18:00 - 1 hour - 17.7 MBJoin us as we talk with Dr. Saad Usmani, MD about his new position as Director of Clinical Research for Hematologic Malignancies and Director of Plasma Cell Disorders at the Levine Cancer Institute and his clinical trials for high-risk myeloma patients. Dr. Usmani was formerly at UAMS.
mPatient Myeloma Radio: Dr. Saad Usmani, MD, Levine Cancer Institute
June 27, 2014 18:00 - 1 hour - 17.7 MBJoin us as we talk with Dr. Saad Usmani, MD about his new position as Director of Clinical Research for Hematologic Malignancies and Director of Plasma Cell Disorders at the Levine Cancer Institute and his clinical trials for high-risk myeloma patients. Dr. Usmani was formerly at UAMS.
HealthTree Podcast for Myeloma: Dr. Brendan Weiss, Abramson Cancer Center, UPENN
June 06, 2014 14:00 - 1 hour - 16.9 MBHear from Dr. Brendan Weiss, MD from the Abramson Cancer Center at the University of Pennsylvania about the indicators and factors that can MGUS progression to myeloma and a host of immunotherapy approaches that are up-and-coming both in the lab and clinic. He will also share his work on the bone marrow environment, how obesity impacts transplant, and how MGUS in racial groups.
mPatient Myeloma Radio: Dr. Brendan Weiss, Abramson Cancer Center, UPENN
June 06, 2014 14:00 - 1 hour - 16.9 MBHear from Dr. Brendan Weiss, MD from the Abramson Cancer Center at the University of Pennsylvania about the indicators and factors that can MGUS progression to myeloma and a host of immunotherapy approaches that are up-and-coming both in the lab and clinic. He will also share his work on the bone marrow environment, how obesity impacts transplant, and how MGUS in racial groups.
HealthTree Podcast for Myeloma: Dr. Stephen Russell, MD, PhD, Mayo Clinic
May 30, 2014 18:00 - 1 hour - 17.4 MBJoin us as we talk in detail about the recent announcement by the Mayo Clinic on Dr. Stephen Russell, MD, PhD's success in using the measles vaccine to halt myeloma growth. This major announcement was made earlier this week and patients want to know more. Dr. Russell will describe the long road to use vaccines to treat cancer, how that work was connected to myeloma, how it works in myeloma, and what comes next.
mPatient Myeloma Radio: Dr. Stephen Russell, MD, PhD, Mayo Clinic
May 30, 2014 18:00 - 1 hour - 17.4 MBJoin us as we talk in detail about the recent announcement by the Mayo Clinic on Dr. Stephen Russell, MD, PhD's success in using the measles vaccine to halt myeloma growth. This major announcement was made earlier this week and patients want to know more. Dr. Russell will describe the long road to use vaccines to treat cancer, how that work was connected to myeloma, how it works in myeloma, and what comes next.
mPatient Myeloma Radio: Dr. Paul Richardson, MD, Dana-Farber Cancer Institute
May 16, 2014 15:00 - 1 hour - 20.1 MBJoin us as we talk with Dr. Paul Richardson about why and when patients should join a multiple myeloma clinical trial. As a leader in very large myeloma clinical trials, Dr. Richardson will share studies that are moving the bar in myeloma care.
mPatient Myeloma Radio: Dr. Pieter Sonneveld, MD, PhD, Erasmus MC
April 28, 2014 11:30 - 46 minutes - 10.4 MBJoin us as we talk Dr. Pieter Sonneveld, MD, PhD, who is the Chairman of the European Myeloma Network and Chairman of the HOVON Foundation about advances in myeloma in Europe and throughout the world.
mPatient Myeloma Radio: Dr. Walter Kuehl, MD, PhD, Cancer Genetics Branch, NCI
April 25, 2014 15:00 - 1 hour - 16.7 MBJoin us as we talk with myeloma genetics expert Dr. Walter Kuehl, MD, PhD of the National Cancer Institute about the progress being made in segmenting and targeting specific approaches for myeloma. Dr. Kuehl has completed deep research on the various pathways affected by these myeloma "subtypes."
mPatient Myeloma Radio: Dr. Vincent Rajkumar, Mayo Clinic
April 15, 2014 14:30 - 1 hour - 14.8 MBJoin us as we speak with Dr. Vincent Rajkumar, MD of the Mayo Clinic about obesity and race in multiple myeloma.
mPatient Myeloma Radio: Dr. Jonathan Licht, MD, Robert H. Lurie CCC
April 11, 2014 16:00 - 1 hour - 17.2 MBJoin us as we talk with Dr. Jonathan Licht of the Robert H. Lurie Comprehensive Cancer Center and Northwestern University about high risk myeloma.
mPatient Myeloma: Dr. Aaron Rapoport, MD, University of Maryland Cancer Ce
March 28, 2014 13:30 - 1 hour - 16.3 MBJoin us as we talk with Dr. Aaron Rapoport, MD of the University of Maryland Greenbaum Cancer Center about his vaccine approaches and T-cell research in myeloma.
mPatient Myeloma Radio: Dr. Robert Orlowski, MD, PhD, MD Anderson
March 21, 2014 16:00 - 58 minutes - 13.1 MBJoin us as we talk with Dr. Robert Z. Orlowski, MD, PhD of MD Anderson Cancer about immunotherapies and the latest in his myeloma research.
mPatient Radio: Dr. Leif Bergsagel, MD, Mayo Clinic Scottsdale
March 07, 2014 18:00 - 1 hour - 15.9 MBJoin us as we talk with Dr. Leif Bergsagel about his research to subdivide myeloma by genetic type and apply different therapy approaches to these unique variations of myeloma.
mPatient Radio: Dr. Jens Lohr, Dana Farber Cancer Institute and BROAD Institute
February 28, 2014 15:00 - 1 hour - 14.5 MBLearn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer Institute and BROAD Institue recently published an article in Cancer Cell describing the complexity and what it means for myeloma patients.
mPatient Radio: Dr. Phillip McCarthy, Roswell Park Cancer Institute
February 21, 2014 19:30 - 1 hour - 20.6 MBListen as we talk with Dr. Phillip McCarthy of the Roswell Park Cancer Institute about his work in immunotherapy, transplantation and myeloma care.
mPatient Radio: Dr. Damian Green, Fred Hutchinson Cancer Center
February 07, 2014 21:00 - 1 hour - 15.9 MBJoin us as we talk with Dr. Damian Green about radiation, radioimmunotherapy and how progress is being made for high-risk patients in myeloma treatment today.
HealthTree Podcast for Myeloma: Dr. Damian Green, Fred Hutchinson Cancer Center
February 07, 2014 21:00 - 1 hour - 15.9 MBJoin us as we talk with Dr. Damian Green about radiation, radioimmunotherapy and how progress is being made for high-risk patients in myeloma treatment today.
HealthTree Podcast for Myeloma: Dr. Parameswaran Hari, Med College of Wisconsin
January 24, 2014 15:00 - 1 hour - 15.6 MBJoin us as we talk with Dr. ParameswaranHari, MD, MRCP, MS, about transplants, his latest myeloma research and open clinical trials. Dr. Hari is the Armand Quick-William Stapp Professor of Hematology, Section Head of Hematological Malignancies and the Director of the Adult Blood and Marrow Transplant Program at the Medical College of Wisconsin.
mPatient Radio: Dr. Parameswaran Hari, Medical College of Wisconsin
January 24, 2014 15:00 - 1 hour - 15.6 MBJoin us as we talk with Dr. ParameswaranHari, MD, MRCP, MS, about transplants, his latest myeloma research and open clinical trials. Dr. Hari is the Armand Quick-William Stapp Professor of Hematology, Section Head of Hematological Malignancies and the Director of the Adult Blood and Marrow Transplant Program at the Medical College of Wisconsin.
mPatient Radio: Dr. Noopur Raje, Massachusetts General Hospital
January 17, 2014 16:00 - 1 hour - 14.1 MBJoin us as we talk with Dr. Noopur Raje, MD of Massachusetts General Hospital about the research she performs in the Raje Lab to study how the bone marrow environment affects myeloma growth.
HealthTree for Multiple Myeloma: Dr. Noopur Raje, Massachusetts General Hospital
January 17, 2014 16:00 - 1 hour - 14.1 MBJoin us as we talk with Dr. Noopur Raje, MD of Massachusetts General Hospital about the research she performs in the Raje Lab to study how the bone marrow environment affects myeloma growth.
mPatient Radio: Dr. Jatin Shah, MD Anderson
January 10, 2014 16:30 - 1 hour - 16.7 MBJoin us as we talk with Dr. Jatin Shah about his many open mutliple myeloma clinical trials at MD Anderson. With a wave of new approaches just presented at ASH, Dr. Shah discusses the wide variety of clinical trial offerings for myeloma patients (from newly diagnosed to relapsed or refractory) that include the use of monoclonal antibodies and other cell signaling inhibitors that are now being tested in the mix with existing therapies.
HealthTree for Multiple Myeloma: Dr. Jatin Shah, MD Anderson
January 10, 2014 16:30 - 1 hour - 16.7 MBJoin us as we talk with Dr. Jatin Shah about his many open mutliple myeloma clinical trials at MD Anderson. With a wave of new approaches just presented at ASH, Dr. Shah discusses the wide variety of clinical trial offerings for myeloma patients (from newly diagnosed to relapsed or refractory) that include the use of monoclonal antibodies and other cell signaling inhibitors that are now being tested in the mix with existing therapies.
mPatient Radio: Dr. Michael Misialek, Newton-Wellesley
November 08, 2013 18:00 - 1 hour - 15.8 MBWhat do your lab results mean and how can you learn more about your specific type of multiple myeloma? Dr. Michael J. Misialek, MD tells us that we have a pathologist that is ready and waiting to help you understand your disease.
HealthTree Podcast for Multiple Myeloma: Dr. Michael Misialek, Newton-Wellesley
November 08, 2013 18:00 - 1 hour - 15.8 MBWhat do your lab results mean and how can you learn more about your specific type of multiple myeloma? Dr. Michael J. Misialek, MD tells us that we have a pathologist that is ready and waiting to help you understand your disease.
mPatient Myeloma Radio: Dr. Gareth Morgan, ICR
November 01, 2013 15:00 - 1 hour - 14.4 MBJoin us as we speak with Dr. Gareth Morgan from the Institute of Cancer Research as we discuss how we can get to personalized medicine in multiple myeloma.
HealthTree Podcast for Multiple Myeloma: Dr. Gareth Morgan, ICR
November 01, 2013 15:00 - 1 hour - 14.4 MBJoin us as we speak with Dr. Gareth Morgan from the Institute of Cancer Research as we discuss how we can get to personalized medicine in multiple myeloma.
HealthTree Podcast for Multiple Myeloma: Dr. Rodger Tiedemann, UHN
October 18, 2013 17:30 - 54 minutes - 12.2 MBJoin us to discuss with Dr. Rodger Tiedemann of the Ontario Cancer Institute and the Princess Margaret Hospitel his latest discovery about why myeloma keeps returning even after stem cell and combination therapy.
mPatient Myeloma Radio: Dr. Rodger Tiedemann, UHN
October 18, 2013 17:30 - 54 minutes - 12.2 MBJoin us to discuss with Dr. Rodger Tiedemann of the Ontario Cancer Institute and the Princess Margaret Hospitel his latest discovery about why myeloma keeps returning even after stem cell and combination therapy.
HealthTree Podcast for Multiple Myeloma: Dr. Rafael Fonseca, Mayo Scottsdale
October 11, 2013 20:00 - 59 minutes - 13.3 MBListen to cytogenetics and genomics expert Dr. Rafael Fonseca, MD of the Mayo Clinic in Scottsdale share the latest in his myeloma research and his open clinical trials.
mPatient Myeloma Radio: Dr. Rafael Fonseca, Mayo Scottsdale
October 11, 2013 20:00 - 59 minutes - 13.3 MBListen to cytogenetics and genomics expert Dr. Rafael Fonseca, MD of the Mayo Clinic in Scottsdale share the latest in his myeloma research and his open clinical trials.
mPatient Myeloma Radio: Dr.Frits van Rhee, UAMS
October 04, 2013 14:00 - 53 minutes - 12 MBHear myeloma expert Dr. Frits van Rhee, MD, PhD from the University of Arkansas for Medical Sciences discuss the latest research in Total Therapy and open clinical trials at UAMS.
HealthTree Podcast for Multiple Myeloma: Dr.Frits van Rhee, UAMS
October 04, 2013 14:00 - 53 minutes - 12 MBHear myeloma expert Dr. Frits van Rhee, MD, PhD from the University of Arkansas for Medical Sciences discuss the latest research in Total Therapy and open clinical trials at UAMS.
mPatient Myeloma Radio: Dr. Shaji Kumar, Mayo Clinic
September 27, 2013 22:00 - 1 hour - 14.1 MBListen to Dr. Shaji Kumar, MD of the Mayo Clinic in Rochester as he describes how all myeloma was once MGUS, how new inhibitors (like CDK and HDAC) work, and his study of how cytogenetics impacts disease progression.
HealthTree Podcast for Multiple Myeloma: Dr. Shaji Kumar, Mayo Clinic
September 27, 2013 22:00 - 1 hour - 14.1 MBListen to Dr. Shaji Kumar, MD of the Mayo Clinic in Rochester as he describes how all myeloma was once MGUS, how new inhibitors (like CDK and HDAC) work, and his study of how cytogenetics impacts disease progression.
mPatient Myeloma Radio: Dr. Sergio Giralt, MSKCC
September 20, 2013 15:00 - 46 minutes - 10.4 MBListen to our next show with Dr. Sergio Giralt of the Memorial Sloan-Kettering Cancer Center to hear about his deep expertise in transplantation and his latest trials including the use of a vaccine in combination with transplant and a gene-targeted approach using cabozantinib.
HealthTree Podcast for Multiple Myeloma: Dr. Sergio Giralt, MSKCC
September 20, 2013 15:00 - 46 minutes - 10.4 MBListen to our next show with Dr. Sergio Giralt of the Memorial Sloan-Kettering Cancer Center to hear about his deep expertise in transplantation and his latest trials including the use of a vaccine in combination with transplant and a gene-targeted approach using cabozantinib.
HealthTree Podcast for Multiple Myeloma: Dr. Craig Crews, Crews Lab at Yale U
September 12, 2013 16:00 - 42 minutes - 9.55 MBListen to Dr. Craig Crews of the Crews Laboratory at Yale University describe how a drug begins as an idea and becomes a real myeloma therapy used in the clinic. He shares his story of the discovery and development of the drug carfilzomib (Kyprolis).
mPatient Myeloma Radio: Dr. Craig Crews, Crews Lab at Yale U
September 12, 2013 16:00 - 42 minutes - 9.55 MBListen to Dr. Craig Crews of the Crews Laboratory at Yale University describe how a drug begins as an idea and becomes a real myeloma therapy used in the clinic. He shares his story of the discovery and development of the drug carfilzomib (Kyprolis).
HealthTree Podcast for Multiple Myeloma: Dr. James R. Berenson, IMBCR
September 06, 2013 22:00 - 1 hour - 14 MBThis week on HealthTree Podcast for Multiple Myeloma we welcome Dr. James Berenson of the Institute for Myeloma & Bone Cancer Research (IMBCR) to discuss the latest in his research and his open clinical trials.
mPatient Myeloma Radio: Dr. James R. Berenson, IMBCR
September 06, 2013 22:00 - 1 hour - 14 MBThis week on mPatient Myeloma Radio we welcome Dr. James Berenson of the Institute for Myeloma & Bone Cancer Research (IMBCR) to discuss the latest in his research and his open clinical trials.
mPatient Myeloma Radio: Dr. William Bensinger, FHCRC
August 30, 2013 18:00 - 56 minutes - 12.6 MBThis week on mPatient Myeloma Radio, we welcome Dr. William Bensinger of the Fred Hutchinson Cancer Research Center to discuss his research and many trials including a Kyprolis trial. With the recent announcement of Amgen's purchase of Onyx, we will be asking how we can continue to fast-track drug development for multiple myeloma.
HealthTree Podcast for Multiple Myeloma: Dr. William Bensinger, FHCRC
August 30, 2013 18:00 - 56 minutes - 12.6 MBThis week on HealthTree Podcast for Multiple Myeloma, we welcome Dr. William Bensinger of the Fred Hutchinson Cancer Research Center to discuss his research and many trials including a Kyprolis trial. With the recent announcement of Amgen's purchase of Onyx, we will be asking how we can continue to fast-track drug development for multiple myeloma.
mPatient Myeloma Radio: Dr. Don Benson The James Ohio State
August 16, 2013 20:00 - 57 minutes - 13 MBThis week on mPatient Myeloma Radio, we welcome Dr. Don Benson of The James Comprehensive Cancer Center at Ohio State University back to discuss his research in nk cells, immunotherapy, and an upcoming PD-1 trial.
HealthTree Podcast for Multiple Myeloma: Dr. Don Benson The James Ohio State
August 16, 2013 20:00 - 57 minutes - 13 MBThis week on HealthTree Podcast for Multiple Myeloma we welcome Dr. Don Benson of The James Comprehensive Cancer Center at Ohio State University back to discuss his research in nk cells, immunotherapy, and an upcoming PD-1 trial.